Helicobacter pylori cell wall and membrane components; thiol-containing bacterial proteins and enzymes

This target profile encompasses the structural and functional components of Helicobacter pylori, a Gram-negative bacterium that colonizes the human gastric mucosa. The target includes the bacterial cell wall, membrane-bound proteins, and various cytoplasmic enzymes that contain thiol (sulfhydryl) groups, which are critical for the organism's survival and pathogenesis (Source: PubMed, PMID: 28643441). Bismuth-based drugs are particularly effective against these targets because bismuth has a high affinity for thiols, leading to the inhibition of critical enzymes like urease, which the bacterium uses to neutralize stomach acid (Source: PubChem). Additionally, the cell wall components are targeted by standard antibiotics such as amoxicillin, which disrupt peptidoglycan synthesis and lead to bacterial lysis (Source: StatPearls). Targeting these diverse elements is essential for the successful eradication of H. pylori, thereby treating chronic gastritis and peptic ulcers while significantly reducing the risk of gastric adenocarcinoma (Source: NIH). This multi-target approach is a cornerstone of triple and quadruple therapy regimens used in clinical practice.

Other names

H. pylori cell wallH. pylori membrane proteinsThiol-containing bacterial enzymesBismuth targets in H. pyloriHelicobacter pylori urease and thiol proteins

Bismuth compounds exert bactericidal effects by binding with high affinity to thiol (sulfhydryl) groups in essential bacterial enzymes such as urease and fumarate reductase, leading to enzyme inactivation and disruption of the bacterial cell wall and plasma membrane (Source: PubChem; PubMed, PMID: 10945311). Antibiotics like amoxicillin inhibit the synthesis of the peptidoglycan layer of the cell wall by binding to penicillin-binding proteins (Source: StatPearls).